BVF Inc’s Repare Therapeutics RPTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-10,333,600
| Closed | -$26.9M | – | 45 |
|
|
2025
Q4 | $26.9M | Hold |
10,333,600
| – | – | 0.9% | 29 |
|
|
2025
Q3 | $18.2M | Hold |
10,333,600
| – | – | 0.74% | 29 |
|
|
2025
Q2 | $14.4M | Hold |
10,333,600
| – | – | 0.51% | 30 |
|
|
2025
Q1 | $10.2M | Hold |
10,333,600
| – | – | 0.42% | 33 |
|
|
2024
Q4 | $13.5M | Hold |
10,333,600
| – | – | 0.46% | 35 |
|
|
2024
Q3 | $35.5M | Hold |
10,333,600
| – | – | 1.04% | 28 |
|
|
2024
Q2 | $34.1M | Hold |
10,333,600
| – | – | 0.96% | 28 |
|
|
2024
Q1 | $48.7M | Hold |
10,333,600
| – | – | 1.34% | 22 |
|
|
2023
Q4 | $75.4M | Buy |
10,333,600
+2,041,612
| +25% | +$11.4M | 1.89% | 13 |
|
|
2023
Q3 | $100M | Hold |
8,291,988
| – | – | 2.7% | 8 |
|
|
2023
Q2 | $87.7M | Hold |
8,291,988
| – | – | 2.45% | 11 |
|
|
2023
Q1 | $81.6M | Hold |
8,291,988
| – | – | 2.98% | 9 |
|
|
2022
Q4 | $122M | Hold |
8,291,988
| – | – | 5.15% | 3 |
|
|
2022
Q3 | $101M | Hold |
8,291,988
| – | – | 4.15% | 5 |
|
|
2022
Q2 | $116M | Buy |
8,291,988
+2,433,212
| +42% | +$28.7M | 5.6% | 1 |
|
|
2022
Q1 | $83.4M | Buy |
5,858,776
+1,000,015
| +21% | +$14.8M | 3.34% | 9 |
|
|
2021
Q4 | $102M | Buy |
4,858,761
+1,136,363
| +31% | +$26.8M | 3.72% | 7 |
|
|
2021
Q3 | $97.7M | Hold |
3,722,398
| – | – | 3.81% | 7 |
|
|
2021
Q2 | $116M | Hold |
3,722,398
| – | – | 4.35% | 8 |
|
|
2021
Q1 | $114M | Buy |
3,722,398
+750,207
| +25% | +$25.5M | 4.28% | 6 |
|
|
2020
Q4 | $102M | Sell |
2,972,191
-92,543
| -3% | -$2.77M | 4.01% | 6 |
|
|
2020
Q3 | $94.3M | Buy |
3,064,734
+1,120,188
| +58% | +$29.7M | 5.14% | 3 |
|
|
2020
Q2 | $60.3M | Buy |
+1,944,546
| New | +$62.4M | 3.72% | 9 |
|
BVF Inc's RPTX Position: Q1 2026 in Review
BVF Inc sold out of Repare Therapeutics (RPTX) in Q1 2026, closing a stake of 10,333,600 shares — an estimated $26.9M sold.
BVF Inc first reported a position in RPTX in Q2 2020 and held it in 23 quarters. The position peaked at $122M in Q4 2022. 0 funds tracked by Wall St. Rank hold RPTX as of Q1 2026.
- BVF Inc reported no remaining Repare Therapeutics position as of Q1 2026 after selling out during the quarter.
- BVF Inc sold 10,333,600 Repare Therapeutics shares in Q1 2026, an estimated $26.9M.
- BVF Inc first reported a position in Repare Therapeutics in Q2 2020 and held it in 23 quarters.
- BVF Inc's Repare Therapeutics position peaked at $122M in Q4 2022.
- 0 funds tracked by Wall St. Rank held Repare Therapeutics as of Q1 2026.
Based on BVF Inc's 13F filing for Q1 2026, filed 15 May 2026.